Hemab Therapeutics and Seaport Therapeutics made their trading debuts on NASDAQ on Friday3
The two companies raised over $550M in gross proceeds combined3
Hemab raked in $301.5 million from its offering1
Seaport raised $254.9 million in its offering1
Shares of both companies surged following their debuts3
Sources:
1. https://firstwordpharma.com
3. https://www.ainvest.com/news/clinical-stage-biotechs-hemab-seaport-surge-debut-raising-550m-upsized-offerings-2605/